About
Developing Therapies to Benefit Patients.
Anaveon’s mission is to harness the power of the immune system for life-saving treatments. The Company was founded in 2017 by scientists and industry experts, who aspire to invent and develop therapeutic treatments that benefit patients and society.
This remains our vision today. Anaveon is a global clinical stage biopharmaceutical company that specializes in developing novel treatments for diseases with high unmet needs. The team has the skills and capabilites to make this vision a reality: we are committed to transforming immunological insights into life-saving therapies.
Our investors share our vision and have backed Anaveon with funding of more than 146 million CHF to date.
Our dedicated team of experts in immunology, protein engineering, & oncology have decades of experience in drug discovery and clinical development, supplemented by strong business expertise ranging from investment to operations. The team’s experience, curiosity, and drive to deliver tangible results set us apart.